FLORIDA INTERNATIONAL UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- 6.5K
- Market Cap
- -
- Website
- http://www.fiu.edu
Clinical Trials
94
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (88 trials with phase data)• Click on a phase to view related trials
Evaluating a Mat-Based Biometric Vibration System for Sleep and Daily Recovery
- Conditions
- Healthy Adult Male and Female Volunteers
- First Posted Date
- 2025-10-27
- Last Posted Date
- 2025-10-27
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 50
- Registration Number
- NCT07221318
- Locations
- 🇺🇸
Florida International University, Biscaney Bay Campus, Miami, Florida, United States
Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
- Conditions
- Post-Surgical Pain, ChronicPost-traumatic Pain, Chronic
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 50
- Registration Number
- NCT07199361
- Locations
- 🇺🇸
Ambulatory Care Center, Florida International University, Miami, Florida, United States
A Reinforced Mindfulness-Based Intervention to Reduce Problematic Drinking Among Hispanic Emerging Adults
- Conditions
- MBSRYoung AdultsHeavy Episodic Drinking
- First Posted Date
- 2025-09-25
- Last Posted Date
- 2025-09-25
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 120
- Registration Number
- NCT07192094
- Locations
- 🇺🇸
Academic Health Center 5 (AHC 5), Miami, Florida, United States
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
- Conditions
- Vaping BehaviorsVaping TeensTobacco Use DisorderVaping Cessation
- First Posted Date
- 2025-09-25
- Last Posted Date
- 2025-09-25
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 120
- Registration Number
- NCT07192601
- Locations
- 🇺🇸
FIU Center for Children and Families, Miami, Florida, United States
Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention
- Conditions
- Type 2 Diabetes (T2DM)
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-11-06
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 5000
- Registration Number
- NCT07155902
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
Proton Therapy Shows Survival Benefit in Glioblastoma Trial, Advances to Phase III
The NRG-BN001 Phase II trial demonstrated that proton therapy at 75 Gy improved overall survival in newly diagnosed glioblastoma patients compared to standard photon therapy.
Florida Launches First-in-Nation Newborn Genetic Screening Program with $7.5 Million State Investment
Florida becomes the first state to offer comprehensive newborn genetic screening through the Sunshine Genetics Pilot Program, providing free genetic sequencing to identify serious but treatable conditions before symptoms appear.
First Ascent Biomedical Secures Florida Grant to Expand AI-Driven Cancer Treatment Platform
First Ascent Biomedical's xDRIVE Drug Prediction Platform, showing 83% improvement in treatment outcomes, receives funding from Florida Cancer Innovation Fund to expand personalized cancer care access.
Precision Medicine and AI Drive Major Advances in Cancer Treatment Outcomes
Miami Cancer Institute reports significant progress in cancer treatment through precision medicine and AI integration, revolutionizing patient care through comprehensive genomic testing and personalized treatment approaches.